Stress sensitivity and the development of affective disorders (Q36562303)

14 August 2017

1 reference

title

Stress sensitivity and the development of affective disorders (English)

1 reference

14 August 2017

Tracy L Bale

1

1 reference

14 August 2017

8 August 2006

1 reference

14 August 2017

Hormones and Behaviour

1 reference

14 August 2017

50

1 reference

14 August 2017

529-533

1 reference

14 August 2017

4

1 reference

Stress effects on limbic function and behavior

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Amygdala kindling, anxiety, and corticotrophin releasing factor (CRF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Increased mRNA for corticotrophin releasing hormone in the amygdala of fawn-hooded rats: a potential animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Elevated CSF CRF in suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

The role of corticotropin-releasing factor in depression and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

CRF and CRF receptors: role in stress responsivity and other behaviors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Inducible cAMP early repressor regulates corticosterone suppression after tricyclic antidepressant treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Gender differences in depression and antidepressant pharmacokinetics and adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Chronic electroconvulsive shock treatment elicits up-regulation of CRF and AVP mRNA in select populations of neuroendocrine neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Effects of Corticotropin-Releasing Factor on Neuronal Activity in the Serotonergic Dorsal Raphe Nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

The role of functional neuroimaging in the neuropsychology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Peripheral and central sex steroids have differential effects on the HPA axis of male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Dopamine-beta-hydroxylase activity is necessary for hypothalamo-pituitary-adrenal (HPA) responses to ether, and stress-induced facilitation of subsequent HPA responses to acute ether emerges as HPA responses are inhibited by increasing corticosteron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

The role of corticotropin-releasing factor in the pathogenesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Corticotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission: an in vivo microdialysis study in mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Effects of corticotropin-releasing factor on brain serotonergic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Studies of the Nature of the Interaction between Vasopressin and Corticotropin-Releasing Factor on Adrenocorticotropin Release in the Rat*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Circuitry underlying regulation of the serotonergic system by swim stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Psychopathology in women and men: focus on female hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Monoaminergic activity in subregions of raphé nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Selectively bred Wistar–Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YHBEH.2006.06.033

10.1016/J.YHBEH.2006.06.033

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16901485